MORC6 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
MORC6 antibody; CRH6 antibody; DMS11 antibody; At1g19100 antibody; F14D16.25 antibody; Protein MICRORCHIDIA 6 antibody; AtMORC6 antibody; EC 3.6.-.- antibody; Protein CRT1-homolog 6 antibody; CRT1-h6 antibody; Protein DEFECTIVE IN MERISTEM SILENCING 11 antibody
Target Names
MORC6
Uniprot No.

Target Background

Function

MORC6 plays a crucial role in RNA-directed DNA methylation (RdDM) as a component of the RdDM machinery, essential for gene silencing. In collaboration with SUVH2 and SUVH9, it regulates the silencing of certain transposable elements (TEs). MORC6 exhibits ATPase activity and may contribute to the regulation of chromatin architecture and condensation to maintain gene silencing. It binds DNA/RNA non-specifically and possesses endonuclease activity, potentially participating in DNA repair. Furthermore, MORC6 acts as a positive regulator in defense against the oomycete Hyaloperonospora arabidopsidis (Hpa).

Gene References Into Functions
  1. Research indicates that MORC6 influences RNA-directed DNA methylation and operates independently of DNA methylation. [MORC6] PMID: 23675613
  2. Mutations in AtMORC1 and AtMORC6 result in the derepression of DNA-methylated genes and transposable elements, without affecting DNA or histone methylation levels. AtMORC1 and AtMORC6 belong to the conserved Microrchidia (MORC) ATPase family, predicted to catalyze alterations in chromosome superstructure. [MORC6] PMID: 22555433
Database Links

KEGG: ath:AT1G19100

STRING: 3702.AT1G19100.1

UniGene: At.41761

Protein Families
MORC ATPase protein family
Subcellular Location
Nucleus.

Q&A

How to validate MORC6 antibody specificity in plant chromatin studies?

Methodological approach:

  • Perform Western blot using Arabidopsis thaliana wild-type and morc6 knockout mutants. Validate absence of signal in mutants .

  • Use immunofluorescence with nuclear markers (e.g., histone H3) to confirm subcellular localization in root tip cells .

  • Conduct peptide competition assays by pre-incubating the antibody with the immunogen peptide; signal reduction confirms specificity .

Key findings:

  • MORC6 colocalizes with RdDM sites and Pol V .

  • Loss of signal in morc6 mutants confirms antibody reliability .

What experimental designs are optimal for studying MORC6’s role in RdDM-dependent vs. RdDM-independent pathways?

Methodological approach:

  • Genetic crosses: Combine morc6 mutants with mom1 or pol V mutants to isolate RdDM-dependent effects .

  • ChIP-seq: Compare MORC6 binding sites in wild-type and RdDM mutants (e.g., nrpe1) to identify RdDM-independent targets .

  • ATAC-seq: Assess chromatin accessibility changes in morc6 mutants to distinguish chromatin compaction roles .

Key findings:

  • MORC6 interacts with PIAL2 in the MOM1 complex for RdDM-dependent silencing .

  • RdDM-independent functions involve chromatin compaction at stress-responsive loci .

How to resolve contradictions in MORC6’s role in DNA methylation maintenance?

Methodological approach:

  • Epistasis analysis: Compare DNA methylation levels in morc6, mom1, and double mutants using whole-genome bisulfite sequencing .

  • Time-course experiments: Track de novo methylation at RdDM targets (e.g., FWA) after ZF-MORC6 tethering in mutant backgrounds .

Key findings:

  • MORC6 acts downstream of MOM1 but upstream of Pol V in RdDM .

  • Partial redundancy with other MORC proteins explains locus-specific methylation defects .

What functional assays confirm MORC6’s interaction with chromatin remodelers?

Methodological approach:

  • Yeast Two-Hybrid (Y2H): Test MORC6’s GHKL domain against PIAL2 or ACD proteins .

  • Co-IP/MS: Immunoprecipitate MORC6-FLAG from transgenic plants and identify co-purifying partners (e.g., MBD–ACD complex) .

  • In vitro ATPase assays: Measure ATP hydrolysis activity of recombinant MORC6 to confirm enzymatic function .

Key findings:

  • MORC6’s GHKL domain mediates interaction with ACD15.5/21.4 .

  • ATPase activity is critical for chromatin compaction .

How to investigate MORC6’s role in human disease models?

Methodological approach:

  • CRISPR knockouts: Generate MORC6-deficient cell lines to assess transcriptional dysregulation (e.g., rDNA silencing) .

  • ChIP-qPCR: Profile MORC6 binding at disease loci (e.g., VAR1 in cancer) under stress conditions .

  • Transcriptome analysis: Compare RNA-seq data from patient samples with MORC6 mutations vs. wild-type .

Key findings:

  • MORC6 depletion disrupts 45S rDNA silencing via MBD–ACD recruitment .

  • MORC6 mutations correlate with autoimmune disorders (e.g., dermatomyositis) .

What controls are essential when using MORC6 antibodies in co-IP experiments?

Methodological approach:

  • Negative controls: Use IgG from pre-immune serum and morc6 mutant lysates .

  • Competition controls: Include immunogen peptide in parallel IPs .

  • Crosslinking optimization: Test formaldehyde vs. DSG crosslinkers for chromatin-bound complexes .

Advanced Research Focus: Integrating MORC6 Data with Multi-Omics

Methodological approach:

TechniqueApplicationExample
CUT&RUNHigh-resolution MORC6 binding profilingCompare RdDM vs. non-RdDM targets
Single-cell RNA-seqResolve stochastic silencing in morc6 mutants Identify cell-autonomous effects
Hi-CMap 3D chromatin restructuring in MORC6-deficient cells Link compaction to TF accessibility

Key findings:

  • MORC6 loss increases DNA accessibility for stress-responsive TFs .

  • Stochastic silencing in morc6 mutants suggests backup silencing mechanisms .

Addressing Technical Limitations in MORC6 Studies

Methodological approach:

  • Multiplexed IF-FISH: Combine immunofluorescence with FISH to correlate MORC6 localization with target loci (e.g., FWA) .

  • Crispr-mediated epitope tagging: Endogenously tag MORC6 for native ChIP-seq .

  • Structure-function analysis: Express MORC6 truncations (e.g., ΔGHKL) to dissect domain roles .

Key findings:

  • MORC6’s GHKL domain is essential for ACD protein interactions .

  • Truncations disrupt RdDM but not chromatin compaction .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.